These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 9222654

  • 1. Ocular vascular endothelial growth factor levels in diabetic rats are elevated before observable retinal proliferative changes.
    Sone H, Kawakami Y, Okuda Y, Sekine Y, Honmura S, Matsuo K, Segawa T, Suzuki H, Yamashita K.
    Diabetologia; 1997 Jun; 40(6):726-30. PubMed ID: 9222654
    [Abstract] [Full Text] [Related]

  • 2. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes.
    Gilbert RE, Vranes D, Berka JL, Kelly DJ, Cox A, Wu LL, Stacker SA, Cooper ME.
    Lab Invest; 1998 Aug; 78(8):1017-27. PubMed ID: 9714188
    [Abstract] [Full Text] [Related]

  • 3. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy.
    Amin RH, Frank RN, Kennedy A, Eliott D, Puklin JE, Abrams GW.
    Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):36-47. PubMed ID: 9008628
    [Abstract] [Full Text] [Related]

  • 4. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas.
    Murata T, Nakagawa K, Khalil A, Ishibashi T, Inomata H, Sueishi K.
    Lab Invest; 1996 Apr; 74(4):819-25. PubMed ID: 8606491
    [Abstract] [Full Text] [Related]

  • 5. High levels of pigment epithelium-derived factor in the retina of a rat model of type 2 diabetes.
    Matsuoka M, Ogata N, Minamino K, Higuchi A, Matsumura M.
    Exp Eye Res; 2006 Jan; 82(1):172-8. PubMed ID: 16054135
    [Abstract] [Full Text] [Related]

  • 6. Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease.
    Vinores SA, Youssri AI, Luna JD, Chen YS, Bhargave S, Vinores MA, Schoenfeld CL, Peng B, Chan CC, LaRochelle W, Green WR, Campochiaro PA.
    Histol Histopathol; 1997 Jan; 12(1):99-109. PubMed ID: 9046048
    [Abstract] [Full Text] [Related]

  • 7. Increased levels of vascular endothelial growth factor and advanced glycation end products in aqueous humor of patients with diabetic retinopathy.
    Endo M, Yanagisawa K, Tsuchida K, Okamoto T, Matsushita T, Higuchi M, Matsuda A, Takeuchi M, Makita Z, Koike T.
    Horm Metab Res; 2001 May; 33(5):317-22. PubMed ID: 11440280
    [Abstract] [Full Text] [Related]

  • 8. Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumours.
    Stitt AW, Simpson DA, Boocock C, Gardiner TA, Murphy GM, Archer DB.
    J Pathol; 1998 Nov; 186(3):306-12. PubMed ID: 10211121
    [Abstract] [Full Text] [Related]

  • 9. Insulin-induced vascular endothelial growth factor expression in retina.
    Lu M, Amano S, Miyamoto K, Garland R, Keough K, Qin W, Adamis AP.
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3281-6. PubMed ID: 10586954
    [Abstract] [Full Text] [Related]

  • 10. The temporal and spatial vascular endothelial growth factor expression in retinal vasculogenesis of rat neonates.
    Murata T, Nakagawa K, Khalil A, Ishibashi T, Inomata H, Sueishi K.
    Lab Invest; 1996 Jan; 74(1):68-77. PubMed ID: 8569199
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of retinal microcirculatory alterations in the Goto-Kakizaki rat. A spontaneous model of non-insulin-dependent diabetes.
    Miyamoto K, Ogura Y, Nishiwaki H, Matsuda N, Honda Y, Kato S, Ishida H, Seino Y.
    Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):898-905. PubMed ID: 8603874
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy.
    Hogeboom van Buggenum IM, Polak BC, Reichert-Thoen JW, de Vries-Knoppert WA, van Hinsbergh VW, Tangelder GJ.
    Diabetologia; 2002 Feb; 45(2):203-9. PubMed ID: 11935151
    [Abstract] [Full Text] [Related]

  • 13. Constitutive expression of VEGF, VEGFR-1, and VEGFR-2 in normal eyes.
    Kim I, Ryan AM, Rohan R, Amano S, Agular S, Miller JW, Adamis AP.
    Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2115-21. PubMed ID: 10440268
    [Abstract] [Full Text] [Related]

  • 14. Vascular endothelial growth factor- and platelet-derived growth factor-angiogenesis depressed but fetal bovine serum-angiogenesis enhanced choroidal tissue cultures of streptozotocin-diabetic Wistar and GK rats.
    Kimura I, Yanagita S, Kobayshi S, Fukuta M, Okabe M.
    Int Angiol; 2000 Mar; 19(1):26-34. PubMed ID: 10853682
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of vascular endothelial growth factor (VEGF) does not affect early renal changes in a rat model of lean type 2 diabetes.
    Schrijvers BF, De Vriese AS, Tilton RG, Van de Voorde J, Denner L, Lameire NH, Flyvbjerg A.
    Horm Metab Res; 2005 Jan; 37(1):21-5. PubMed ID: 15702434
    [Abstract] [Full Text] [Related]

  • 16. Clinical factors related to the aqueous levels of vascular endothelial growth factor and hepatocyte growth factor in proliferative diabetic retinopathy.
    Shinoda K, Ishida S, Kawashima S, Wakabayashi T, Uchita M, Matsuzaki T, Takayama M, Shinmura K, Yamada M.
    Curr Eye Res; 2000 Aug; 21(2):655-61. PubMed ID: 11148602
    [Abstract] [Full Text] [Related]

  • 17. Diabetes-Induced Inflammation and Vascular Alterations in the Goto-Kakizaki Rat Retina.
    Hachana S, Pouliot M, Couture R, Vaucher E.
    Curr Eye Res; 2020 Aug; 45(8):965-974. PubMed ID: 31902231
    [Abstract] [Full Text] [Related]

  • 18. Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy.
    Mathews MK, Merges C, McLeod DS, Lutty GA.
    Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2729-41. PubMed ID: 9418725
    [Abstract] [Full Text] [Related]

  • 19. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.
    Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE.
    N Engl J Med; 1994 Dec 01; 331(22):1480-7. PubMed ID: 7526212
    [Abstract] [Full Text] [Related]

  • 20. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy.
    Watanabe D, Suzuma K, Matsui S, Kurimoto M, Kiryu J, Kita M, Suzuma I, Ohashi H, Ojima T, Murakami T, Kobayashi T, Masuda S, Nagao M, Yoshimura N, Takagi H.
    N Engl J Med; 2005 Aug 25; 353(8):782-92. PubMed ID: 16120858
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.